In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Mikkael Sekeres, Professor of Medicine and Chief of the Division of Hematology at the University of Miami.

Together, they explore the complex landscape of acute myeloid leukemia (AML), discussing the latest advancements in diagnosis, treatment options, and risk stratification.

Key topics included:
•⁠ ⁠The importance of molecular testing in AML diagnosis and treatment planning
•⁠ ⁠The role of intensive induction chemotherapy and the classic 7+3 regimen
•⁠ ⁠New oral therapies, including FLT3 inhibitors and hypomethylating agents combined with venetoclax
•⁠ ⁠Strategies for managing elderly or frail patients who are ineligible for intensive chemotherapy
•⁠ ⁠The significance of measurable residual disease (MRD) in treatment decisions and transplant eligibility
•⁠ ⁠Insights into managing side effects and complications associated with AML treatments

Join us for an informative discussion that sheds light on the evolving treatment landscape of AML and the importance of personalized care in oncology. Don't forget to check out our other episodes on hematological malignancies, and we look forward to seeing you at ASH 2024!

Subscribe to our channel for more insights and updates in the world of oncology!

Website: [ Ссылка ]

X/Twitter: [ Ссылка ]

Contact us at info@oncbrothers.com

свернуть